1
Molekuláris Immunologia és Toxikológia Osztály (MITO) A munkatársak publikációs listája Nagy P, Lechte TP, Das AB, Winterbourn CC Conjugation of Glutathione to Oxidized Tyrosine Residues in Peptides and Proteins Journal of Biological Chemistry (2012) epub. ahead of print Budai B, Komlósi V, Adleff V, Pap É, Réti A, Nagy T, Kralovánszky J, Láng I, Hitre E Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab Pharmacogenet Genomics (2012) 22, 69-72 Döme P, Halmai Z, Dobos J, Lazary J, Gonda X, Kenessey I, Sallai T, Makkos Z, Faludi G Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression J Affect Disord (2012) 136, 1159-1163 Umansky V, Malyguinea A, Kotlan B, Aptsiauri N, Shurin MR From cell regulation to patient survival Cancer Immunol Immunother (2012) 61, 295-301 Dobos J, Kenessey I, Tímár J, Ladányi A Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells Pathol Oncol Res (2011) 17, 729-734 Nagy P, Karton A, Betz A, Peskin AV, Pace P, O'Reilly R, Hampton MB, Radom L, Winterbourn CC Model for the exceptional reactivity of peroxiredoxins 2 and 3 with hydrogen peroxide; a kinetic and computational study J Biol Chem (2011) 286, 18048-18055 Pálinkás Z, Baranyai Zs, Brücher E, Rózsa B Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2- and Gd(DTPA-BMA), used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand Inorg Chem (2011) 50, 3471-3478 Afzal S, Gusella M, Jensen SA, Vainer B, Vogel U, Andersen JT, Brødbæk K, Petersen M, JimenezSolem E, Adleff V, Budai B, Hitre E, Láng I, Orosz E, Bertolaso L, Barile C, Padrini R, Kralovánszky J, Pasini F, Poulsen HE The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer Pharmacogenomics (2011) 12, 1257-1267 Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejös Z, Gaudi I, Dobos J, Tímár J Prognostic impact of B-cell density in cutaneous melanoma Cancer Immunol Immunother (2011) 60, 1729-1738 Polgári Z, Ajtony Z, Kregsamer P, Streli C, Mihucz VG, Réti A, Budai B, Kralovánszky J, Szoboszlai N, Záray G Microanalytical method development for Fe, Cu and Zn determination in colorectal cancer cells
2 Talanta (2011) 85, 1959-1965 Polgári Z, Meirer F, Sasamori S, Ingerle D, Pepponi G, Streli C, Rickers K, Réti A, Budai B, Szoboszlai N, Zaray G Iron speciation in human cancer cells by K-edge total reflection X-ray fluorescence–X-ray absorption near edge structure analysis Spectrochim Acta B (2011) 66, 274-279 Kotlan B, Balwith J M Pioneering the Trail of Cancer Immunotherapy: A summary report of the 25th Annual meeting and associated programs of the International Society for Biological Therapy of Cancer (iSBTc) Expert Rev Anticancer Ther (2011) 11, 351-354 Kotlan B, Umansky V, Malyguinea A, Marincola FM, Shurin MR Immunotherapy reaches new milestones in cancer eradication: 2nd Cancer immunotherapy and immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011 Immunotherapy (2011) 3, 1131-1137 Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, deGruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Hakansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilhotz U, Khleif SN, Kiessling R, Kotlan B, … Disis ML et al. Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 9, 214-253 Nagy P, Kettle AJ, Winterbourn CC Neutrophil-mediated oxidation of enkephalins via myeloperoxidase-dependent addition of superoxide Free Radic Biol Med (2010) 49, 792-799 Nagy P, Winterbourn CC Redox chemistry of biological thiols In: Advances in Molecular Toxicology Ed: Fishbein JC Elsevier, 2010, p. 183-222 Nagy P, Winterbourn CC Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides Chem Res Toxicol (2010) 23, 1541-1543 Baranyai Zs, Pálinkás Z, Uggeri F, Brücher E Equilibrium studies on the Gd3+, Cu2+ and Zn2+ complexes of BOPTA, DTPA and DTPA-BMA ligands: kinetics of metal-exchange reactions of [Gd(BOPTA)]2– Eur J Inorg Chem (2010) 2010, 1948–1956 Berta J, Kenessey I, Dobos J, Tóvári J, Klepetko W, Jan Ankersmit H, Hegedős B, Rényi-Vámos F, Varga J, Lırincz Z, Paku S, Ostoros G, Rózsás A, Tímár J, Döme B Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis J Thorac Oncol (2010) 5, 1120-1129 Bozonet SM, Scott-Thomas A, Nagy P, Vissers MCM Hypothiocyanous acid is a potent inhibitor of apoptosis and caspase-3 activation in endothelial cells
3 Free Radical Biol Med (2010) 49, 1054-1063 Das AB, Nagy P, Abbott H, Winterbourn CC, Kettle AJ Superoxide reacts with myoglobin tyrosyl radical via both addition and electron transfer Free Radical Biol Med (2010) 48, 1540-1547 Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, Tímár J, Tóvári J. Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma Curr Cancer Drug Targets (2010) 10, 332-342 Komlósi V, Hitre E, Pap E, Adleff V, Réti A, Székely E, Bíró A, Rudnai P, Schoket B, Müller J, Tóth B, Ottó S, Kásler M, Kralovánszky J, Budai B SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer BMC Cancer (2010) 10, 525 Peskin AV, Cox AG, Nagy P, Morgan PE, Davies MJ, Hampton MB, Winterbourn CC Rapid removal of amino acid, peptide and protein hydroperoxides by reaction with peroxiredoxin 2&3 Biochemical J (2010) 432, 313-321 Réti A, Pap É, Adleff V, Jeney A, Kralovánszky J, Budai B Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase Cancer Chemother Pharmacol (2010) 66, 219-227 Vereczkey I, Serester O, Dobos J, Gallai M, Szakács O, Szentirmay Z, Tóth E Molecular characterization of 103 ovarian serous and mucinous tumors Pathol Oncol Res (2010) 17, 551-559 Kotlan B 15th International Conference on Human Antibodies and Hybridomas: Summary and update. Immunotherapy (2010) 2, 761-765 Budai B A daganatellenes gyógyszerek farmakogenetikai vizsgálatainak összefoglaló ismertetése In: Onkofarmakológia Eds: Jeney A, Kralovánszky J Medicina Könyvkiadó Zrt, Budapest, 2009, p. 989-1050 Dobos J. A melanóma progresszióját befolyásoló endokrin tényezık Magy Onkol (2009) 53, 47-50 Kotlan B, Stroncek DF, Marincola FM Turning laboratory findings into therapy: a marathon goal that has to be reached! Pol Arch Med Wewn (2009) 119, 586-593 Kotlan B, Stroncek DF, Marincola FM. Intravenous immunoglobulin-based immunotherapy: An arsenal of possibilities for patients and science Immunotherapy (2009) 1, 995-1014 Kotlan B, Glassy MC Antibody phage display – a powerful technology that has quickly opened windows into the clinic.
4 Methods Mol Biol (2009) 562, 1-15 Nagy P, Jameson GNL, Winterbourn CC Kinetics and mechanisms of the reaction of hypothiocyanous acid with reduced glutathione and 5thio-2-nitrobenzoic acid Chem Res Toxicol (2009) 22, 1833-1840 Nagy P, Kettle AJ, Winterbourn CC Superoxide-mediated formation of tyrosine hydroperoxides and methionine sulfoxide in peptides through radical addition and intramolecular oxygen transfer J Biol Chem (2009) 284, 14723-14733 Pálinkás Z, Roca-Sabio A, Mato-Iglesias M, Esteban-Gómez D, Platas-Iglesias C, de Blas A, Rodríguez-Blas T, Tóth É Stability, water exchange, and anion binding studies on lanthanide(III) complexes with a macrocyclic ligand based on 1,7-diaza-12-crown-4: extremely fast water exchange on the Gd3+ complex Inorg Chem (2009) 48, 8878-8889 Bogos K, Rényi-Vámos F, Dobos J, Kenessey I, Tóvári J, Tímár J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Láng G, Hoda MA, Nierlich P, Döme B High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cance. Clin Cancer Res (2009) 15, 1741-1746 Döme P, Teleki Z, Rihmer Z, Péter L, Dobos J, Kenessey I, Tóvári J, Tímár J, Paku S, Kovács G, Döme B Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul Mol Psychiatry (2009) 14, 523-531 Kralovánszky J, Budai B, Adleff V A daganatos betegségek prognosztikai és prediktív markerei, a farmakogenetika jelentısége az egyénre szabott gyógyszerválasztásban In: Onkofarmakológia Eds: Jeney A, Kralovánszky J Medicina Könyvkiadó Zrt, Budapest, 2009, p. 549-592 Réti A, Barna G, Pap É, Adleff V, Komlósi V, Jeney A, Kralovánszky J, Budai B Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on Low COX-2 expressing HT-29 cells Pathol Oncol Res (2009) 15, 335-344 Réti A, Barna G, Pap É, Adleff V, Komlósi V, Jeney A, Kralovánszky J, Budai B Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal antiinflammatory drugs in tumor cells and xenografts Anticancer Res (2009) 29, 3095-3101 Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review Am J Epidemiol (2009) 170, 1207-1221 Kotlan B Sejtes és humorális immunválasz szerepe a terhességi immunológiaában In: Az immunológia idıszerő kérdései a humán reprodukcióban Ed: Fülöp V
5 Semmelwess Kiadó és Multimedia Studio, Budapest, 2008, p. 229-237 Kotlan B Novel findings to establish a new generation of breast cancer diagnostic and therapeutic immunoconjugates. In: My Fulbright Experience / Reports of Hungarian Grantees Ed: Nagypal Cs Bruckner H, Hungarian-American Commission for Educational Exchange, 2008, p. 201-218 Nagy P, Ueki H, Berbasov DO, Soloshonok VA Kinetics and mechanism of triethylamine-catalyzed 1,3-proton shift. Optimized and substantially improved reaction conditions for biomimetic reductive amination of fluorine-containing carbonyl compounds J Fluor Chem (2008) 129, 409-415 Bácsi K, Hitre E, Kósa JP, Horváth H, Lazáry A, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population BMC Cancer (2008) 8, 317 Döme B, Dobos J, Tóvári J, Paku S, Kovács G, Ostoros G, Tímár J Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease Cytometry A (2008) 73, 186-193 Mato-Iglesias M, Roca-Sablo A, Pálinkás Z, Esteban-Gómez D, Platas-Iglesias C, Tóth É, de Blas A, Rodríguez-Blas T Lanthanide complexes based on a 1,7-diaza-12-crown-4 platform containing picolinate pendants: a new structural entry for the design of magnetic resonance imaging contrast agents Inorg Chem (2008) 47, 7840-7851 Lövey J, Bereczky B, Gilly R, Kenessey I, Rásó E, Simon E, Dobos J, Vágó A, Kásler M, Döme B, Tímár J, Tóvári J Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels Strahlenther Onkol (2008) 184, 1-7 Szoboszlai N, Réti A, Budai B, Szabó Zs, Kralovánszky J, Záray Gy Direct elemental analysis of cancer cell lines by total reflection X-ray fluorescence Spectrochim Acta B (2008) 63, 1480-1484 Glassy MC, McKnight ME, Kotlan B, Glassy EF, Koda K Cocktails of human anti-cancer antibodies show a synergistic effect in nude mouse tumor xenografts Hum Antibodies (2007) 16, 87-98 Nagy P, Ashby MT Reactive sulfur species: kinetics and mechanisms of the oxidation of cysteine by hypohalous acid to give cysteine sulfenic acid J Am Chem Soc (2007) 129, 14082-14091 Nagy P, Ashby MT Reactive sulfur species: kinetics and mechanism of the hydrolysis of cysteine thiosulfinate ester Chem Res Toxicol (2007) 20, 1364-1372. Nagy P, Ashby MT
6 Kinetics and mechanism of the oxidation of glutathione dimer by hypochlorous acid and catalytic reduction of the dichloroamine product by glutathione reductase Chem Res Toxicol (2007) 20, 79-87 Nagy P, Lemma K, Ashby MT Reactive sulfur species: kinetics and mechanisms of the reaction of cysteine thiosulfinate ester with cysteine to give cysteine sulfenic acid J Org Chem (2007) 72, 8838-8846 Nagy P, Lemma K, Ashby MT Kinetics and mechanism of the comproportionation of hypothiocyanous acid and thiocyanate to give thiocyanogen in acidic aqueous solution Inorg Chem (2007) 46, 285-292 Nagy P, Wang X, Lemma K, Ashby MT Reactive sulfur species: hydrolysis of hypothiocyanite to give thiocarbamate-S-oxide J Am Chem Soc (2007) 129, 15756-15757 Nagy P, Becker JD, Mallo RC, Ashby MT The Jekyll and Hyde roles of cyesteine derivatives during oxidative stress In: New biocides development: the combined approach of chemistry and microbiology Ed: Zhu P ACS Press, Washington DC, 2007, p. 193-212 Ashby MT, Nagy P Revisiting a proposed kinetic model for the reaction of cysteine and hydrogen peroxide via cysteine sulfenic acid Int J Chem Kinet (2007) 39, 32-38 Lövey J, Kenessey I, Rásó E, Dobos J, Vágó A, Kásler M, Futosi K, Döme B, Tímár J, Tóvári J A rekombináns humán erythropoietin-α fokozza a humán laphámrák sugárérzékenységét preklinikai modellben Magy Onkol (2007) 51, 53-61 Kralovánszky J, Adleff V, Hitre E, Pap É, Réti A, Komlósi V, Budai B Farmakogenetikai vizsgálatok a fluoropirimidint tartalmazó adjuváns kezelés hatékonyságának és toxicitásának elırejelzésére colorectalis daganatokban Magy Onkol (2007) 51, 113-125 Remenár É, Számel I, Budai B, Vincze B, Gaudi I, Gundy S, Kásler M: Increase of hypophyseal hormone levels in male head and neck cancer patients Pathol Oncol Res (2007) 13, 341-344 Kotlan B, Tóth J, McKnight M, Glassy MC Characteristics of tumor gangliosides revealed by B cells infiltrating human breast carcinomas Human Antibodies (2006) 15, 9 -13 Kotlan B, Padányi A, Réti M, Gyódi E, Rajczy K, Bátorfi J, Petrányi GGy, Fülöp V Alloimmune and autoimmune background in recurrent pregnancy loss - Successful immunotherapy by IVIG Am J Reprod Immunol (2006) 55, 331-337 Nagy P, Alguindigue SS, Ashby MT Lactoperoxidase-catalyzed oxidation of thiocyanate by hydrogen peroxide: a reinvestigation of hypothiocyanite by nuclear magnetic resonance and optical spectroscopy Biochemistry (2006) 45, 12610-12616
7
Nagy P, Beal JL, Ashby MT Thiocyanate is an efficient endogenous scavenger for the phagocytic killing agent hypobromous acid Chem Res Toxicol (2006) 19, 587-593 Ashby MT, Nagy P On the kinetics and mechanism of the reaction of cysteine and hydrogen peroxide in aqueous solution J Pharm Sci (2006) 95, 15-18 Döme B, Tímár J, Dobos J, Mészáros L, Rásó E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladányi A, Bogos K, Tóvári J Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer Cancer Res (2006) 66, 7341-7347 Kotlan B, Simsa P, Teillaud JL, Fridman WH, Tóth J, McKnight M, Glassy M Novel ganglioside antigen identified by B cells in human medullary breast carcinomas. The proof of principle concerning the infiltrating B lymphocytes J Immunol (2005) 175, 2278-2285 Simsa P, Teillaud JL, Stott I D, Tóth J, Kotlan B Immunoglobulin variable region gene usage of B lymphocytes in ductal breast carcinomas Pathol Oncol Res (2005) 11, 92-97 Nagy P, Ashby MT Reactive sulfur species: kinetics and mechanism of the oxidation of cystine by hypochlorous acid to give N,N’-dichlorocystine Chem Res Toxicol (2005) 18, 919-923 Nagy P, Fischer A, Glaser J, Ilyukhin A, Maliarik M, Tóth I Solubility, complex formation and redox reactions in the Tl2O3-HCN/CN--H2O system. Crystal structures of the cyano compounds: Tl(CN)3·H2O, Na[Tl(CN)4]·3H2O, K[Tl(CN)4], Tl(I)[Tl(III)(CN)4] and of Tl(I)2C2O4 Inorg Chem (2005) 44, 2347-2357 Nagy P, Jószai R, Fábián I, Tóth I, Glaser J The decomposition and formation of the platinum-thallium bond in the [(CN)5Pt-Tl(edta)]4- complex. Kinetics and mechanism J Mol Liq (2005) 118, 195-207 Döme B, Rásó E, Dobos J, Mészáros L, Varga N, Puskás LG, Fehér LZ, Lörincz T, Ladányi A, Trikha M, Honn KV, Tímár J Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype. Int J Cancer (2005) 116, 27-35 Hitre E, Budai B, Adleff V, Czeglédi F, Horváth Zs, Gyergyay F, Lövey J, Kovács T, Orosz Zs, Láng I, Kásler M, Kralovánszky J Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil. Pharmacogenet Genomics (2005) 15, 723-730 Jószai R, Beszeda I, Bényei A, Fischer A, Kovács M, Maliarik M, Nagy P, Shchukarev A, Tóth I Metal-metal bond or isolated metal centers? Reaction of Hg(CN)2 with square planar transition metal cyanides
8 Inorg Chem (2005) 44, 9643-9651 Kralovánszky J, Adleff V, Budai B A daganatok prognosztikai és prediktív markerei, az egyénre szabott gyógyszerkiválasztás lehetııségei. In: Onkofarmakológia Eds: Jeney A, Kralovánszky J Medicina Könyvkiadó Rt, Budapest, 2005, p. 515-550 Budai B, Hitre E, Adleff V, Czeglédi F, Gyergyay F, Láng I, Kralovánszky J A metiléntetrahidrofolát-reduktáz (MTHFR) C677T polimorfizmus klinikai jelentısége a metasztatikus colorectalis daganatok 5-fluoropirimidin alapú kezelésében. Magy Onkol (2004) 48, 253-257 Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer (2004) 112, 771-776 Nagy P, Tóth I, Fábián I, Maliarik M, Glaser J Kinetics and mechanism of platinum-thallium bond formation: the binuclear [(CN)5Pt-Tl(CN)] - and the trinuclear [(CN)5Pt-Tl-Pt(CN)5] 3- complexes Inorg Chem (2004) 43, 5216-5221 Ahmed S, Budai B, Herédi-Szabó K, Farkas J, Tóth G, Murphy RF, Lovas S High and low affinity receptors mediate growth effects of gastrin and gastrin-Gly on DLD-1 human colonic carcinoma cells. FEBS Letters (2004) 556, 199-203 Katona Cs, Tímár F, Oláh J, Bocsi J, Budai B, Ötvös L, Kralovánszky J Az 5-fluorouracil (5-FU) hatékonyságának fokozása. Az 5-FU és 5-etil-2’-dezoxiuridin kombináció hatásában szerepet játszó molekuláris mechanizmusok. Magy Onkol (2004) 48, 243-251 Kralovánszky J, Adleff V, Budai B, Pandi E A kolorektális rákok gyógyszeres terápiájának hatékonyságát meghatározó tényezık. Motesz Magazin (2004) 2, 15-21 Kotlan B, Simsa P, Földi J, Fridman WH, Glassy M, McKnight M, Teillaud JL Immunoglobuline repertoire of B lymphocytes infiltrating human breast medullary carcinoma. Hum Antibodies (2003) 12, 113-121 Nagy P, Tóth I, Fábián I, Maliarik M, Glaser J Kinetics and mechanism of formation of the platinum-thallium bond: the [(CN)5Pt-Tl(CN)3]3- complex Inorg Chemistry (2003) 42, 6907-6914 Remenár É, Számel I, Budai B, Orosz Zs, Gaudi I, Kásler M, Gundy S Szex szteroid- és hypophysishormonszintek prognosztikus jelentısége fej-nyaki laphámrákban. Magy Onkol (2003) 47, 155-159 Kralovánszky J, Köves I, Orosz Zs, Katona Cs, Tóth K, Rahóty P, Czeglédi F, Kovács T, Budai B, Hullán L, Jeney A Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors Oncology (2002) 62, 167-175 Gruel N, Kotlan B, Zafrani B, Teillaud JL Generation of scFv from a phage display mini-library derived from tumor-infiltrating B cells.
9 Methods Mol Biol (2002) 193, 281-300 Petrányi GGy, Kotlan B Tolerance induction: historical and scientific background and recent development in clinical practice. Vox Sang (2002) 83(Suppl 1), 159-165 Remenár É, Számel I, Budai B, Gaudi I, Kásler M, Gundy S Szex szteroid- és hypophysishormonok valamint a májfunkció összehasonlító vizsgálata egészséges, alkoholista és fej-nyaki laphámrákos férfiakban. Magy Onkol (2002) 46, 329-332 Budai B, Számel I, Sulyok Z, Németh M, Kralovánszky J, Bak M, Ottó Sz, Parish DC, Reed MJ Characteristics of cystic breast disese with special regard to the breast cancer development. Anticancer Res (2001) 21, 749-752 Kotlan B, Fülöp V, Padányi A, Szigetvári I, Réti M, Gyódi E, Fehér E, Petrányi GGy High partner antigen specific cytotoxic T lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions. Hum Reprod (2001) 16, 1278-1285 Budai B, Számel I, Sulyok Z, Németh M, Bak M, Kralovánszky J, Ottó Sz, Besznyák I, Purohit A, Parish DC, Reed MJ Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk. Anticancer Res (2000) 20, 3879-3886 Purohit A, Budai B, Wang DY, Willemsen EL, de Winkel A, Parish DC, Ghilchik MW, Szamel I, Reed MJ Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian women. Br J Cancer (2000) 82, 492-496 Kotlan B, Simsa P, Gruel N, Foldi J, Fridman WH, Petrányi GGy, Teillaud JL A scFv phage display mini library generated from the immunoglobulin repertoire of breast medullary carcinoma infiltrating B lymphocytes. Dis Markers (2000) 16, 25-27 Várkonyi J, Zalatnai A, Tímár J, Matolcsi A, Pocsik E, Kotlan B, Császár A, László V Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia. Acta Haematol (2000) 103, 116-121 Kotlan B, Gruel N, Zafrani B, Füredi G, Földi J, Petrányi GGy, Fridman WH, Teillaud JL Immunoglobulin variable regions usage by B-lymphocates infiltrating a human breast medullary carcinoma. Immunol Lett (1999) 65, 143-151 Liszka Gy, Számel I, Pete I, Petrányi Á, Udvarhelyi N, Budai B Investigation of serum sex hormone levels in postmenopausal patients with multiple benign breast lesions detected by mammography. Endocr Rel Cancer (1998) 5, 311-314 Padányi A., Horuzskó A, Gyódi E, Réti M, Pocsik E, Kotlan B, Perner F., Petrányi GGy Humoral and cell mediated factors involved in the suppressive regulation induced by special blood derivates and their clinical relevance. Transplant Proc (1998) 30, 1-5
10
Számel I, Budai B, Sulyok Z, Rahóty P, Bak M, Németh M, Kralovánszky J, Ottó Sz, Besznyák I, Reed MJ A nagycisztás mastopathia és az emlırák rizikó: hormonális és biokémiai markerek az emlıciszta folyadékban. Magy Onkol (1998) 42, 17-23 Számel I, Hindy I, Budai B, Kangas L, Hajba A, Lammintausta R Endocrine mechanism of action of toremifene at the level of the central nervous system in advanced breast cancer patients. Cancer Chemother Pharmacol (1998) 42, 241-246 Budai B, Remenár É, Orosz Zs, Számel I, Kralovánszky J, Kásler M Szteroidhormon-receptorok vizsgálata fej-nyak laphámrákban szenvedı betegeken. Orv Hetil (1997) 138, 723-727 Remenár É, Számel I, Budai B, Orosz Z, Kásler M, Bánhidy F "Why men?" Investigation on the endocrine status and hormone receptors in male patients with cancer of the laryngo-pharyngeal region In: Advances in Laryngology in Europe Eds: Kleinsasser O, Glanz H, Olofsson J Elsevier, 1997, p. 137-140 Számel I, Hindy I, Budai B, Kangas L, Hajba A, Lammintausta R A toremifene központi idegrendszer szintjén kifejtett hatása elırehaladott emlırákos betegekben Magy Onkol (1997) 41, 101-105 Padányi A, Kotlan B, Gyódi E, Perner F, Petrányi GGy Association between long term kidney graft survival and the presence of pre transplant cytotoxic anti HLA and/or non-MHC "blocking" anti-TLX alloantibody in relation to CTL precursor frequency Clin Transplant (1996) 10, 455-460 Számel I, Budai B, Gyergyai F, Erdélyi-Tóth V, Kralovánszky J, Drabant S, Csörgı M, Zsarnóczay Sz Endocrine effects of EGIS-5650 (panomifene) on healthy volunteers: a phase I/a study In: Hormone Dependent Tumors. Eds: Jonat W, Kaufman M, Munk K Karger, 1995, p. 210-220 Petrányi GGy, Padányi A, Kotlan B, Gyódi E, Szigetvári I, Kassay M Cellular and humoral immunologic factors for the protection of trophoblast and embryo in human. Reg Immunol (1995) 6: 306-311 Budai B, Számel I Cathepsin D, pS2 and steroid receptor levels in breast cancer patients In: Advances in Steroid Analysis ’93 Ed: Görög S Akadémiai Kiadó, 1994, p. 51-55 Számel I, Budai B, Daubner K, Kralovánszky J, Ottó Sz, Tóth J, Besznyák I: Hormonal characterization and classification of breast cyst fluid in gross cystic mastopathy Endocr Relat Cancer (1994) 2, 49-55 Számel I, Budai B, Daubner K, Kralovánszky J, Csetényi J, Otto Sz, Besznyák I A nagycisztás mastopathia cisztafolyadékának hormonális és biokémiai jellemzése. Orv Hetil (1994) 135, 907-911 Számel I, Budai B, Gyergyay F, Erdélyi-Tóth V, Kralovánsky J, Drabant S, Csörgö M, Zsarnóczay P
11 Az antiösztrogén hatású új vegyület (EGIS-5650), panomifene) endokrin hatásairól egészséges önkénteseken: fázis I/a vizsgálat. Orv Hetil (1994) 135, 1077-1081 Számel I, Hindy I, Vincze B, Budai B, Kangas L, Hajba A Monitoring of sex hormone and SHBG levels in advanced breast cancer patients treated with toremifene In: Advances in Steroid Analysis ’93 Ed: Görög S. Akadémiai Kiadó, 1994, p. 41-49 Pálóczi K, Natonek K, Pocsik E, Kotlan B, Mihalik R, Benczur M, Demeter J, Petrányi GGy The comparison of the expression of activation antigens on peripheral blood mononuclear cells in chronic lymphocytic leukemia. In: Haematology and blood transfusion, modern trends in human leukemia IX Eds: Neth R et al. Springer Verlag Berlin, 1992, p. 38-40 Phan DT, Benczur M, Pálóczi K, Mihalik R, Kotlan B, Gidáli J, Fehér I, Dömötöri J, Kiss CS, Petrányi Ggy, Hollán SR Early expression of histocompatibility class I, and class II and myeloid antigens on human fetal liver cells. Thymus (1990) 16, 123-127 Kotlan B, Böck G, Rajnavölgyi E, Benczur M, Mátyus L, Gyódi E, Huber C, Petranyi GGy The different effect of alpha and gamma interferons and interleukin-2 on the expression of CD2, CD3, CD4 and CD8 antigens in comparison to histocompatibility antigens of human lymphocytes. Immunol Lett (1988) 18, 259-268 Kotlan B, Gyódi E, Szabó T, Takács K, Troppmair J, Petri I, Padányi A, Kaiser G, Kassay M, Huber C, Petrányi GGy Comparative study on alloimmune reaction induced by leukocyte and platelet transfusion in humans: Characteristic changes of activation markers, gamma interferon and FcR blocking antibody production Hum Immunol (1988) 22, 19-29 Nachbaur K, Troppmair J, Bieling P, Kotlan B, König P, Huber C Cytokines in the control of b2microglobulin release I. In vitro studies on various haemopoietic cells. Immunobiol (1988) 177, 55-65 Nachbaur K, Troppmair J, Kotlan B, König P, Aulitzky W, Bieling P, Huber C Cytokines in the control of b2microglobulin release II. In vivo studies with recombinant interferons and antigens. Immunobiol (1988) 177, 66-75 Troppmair J, Nachbaur K, Herold M, Aulitzky W, Tilg H, Gastl G, Bieling P, Kotlan B, Flener R, Mull B, Aulitzky W, Rokos H, Huber C In vitro and in vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol (1988) 74, 392-397 Kotlan B, Gyódi E, Benczur M, Takács K, Szabó T, Troppmair J, Ónody K, Petri I, Kaiser G, Kassay M, Huber C, Petrányi GGy The expression of activation markers and CD25 antigen on PBL in comparison with the immune function after alloimmunization In: Leukocyte Typing III. White Cell Differentiation Antigens Ed: McMichael AJ Oxford University Press, Oxford, 1987, p. 534-536
12 Huber C, Woloszczuk W, Kotlan B, Bieling P, Troppmair J Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro In: The biology of the Interferon System Eds: Stewart II WE, Schellekens H Elsevier Science Publishers B.V. (Biomed. Div.) 1986, p. 467-470 Petrányi GGy, Pocsik E, Kotlan B, Görög Gy, Benczúr M Regulatory function of cell surface molecules CD2, β2m, and LFA1 in natural killer cell activity. Mol Immunol (1986) 23, 1275-1279 Takács K, Szabó T, Kotlan B, Petri I, Gyódi E, Kaiser G, Kassay M, Huber C, Petrányi GGy In vitro experiments on characteristic changes in functional immune parameters after planned immunisation with "Buffy-coat". Transplant Proc (1986) 18, 1321-1323
